Table 2 Age-gender standardized baseline demographics and laboratory results accordings to eGFR in the entire cohort (n = 1,363)

Age, years

50.1 ± 13.8

57.3 ± 13.8

59.3 ± 13.7

59.4 ± 14.6

0.0001

   T¹⁾

a

b, c

c

c

Sex,%

   Males

46

48.3

54.3

56

   Females

54

51.7

45.7

44

Diabetes,%

52.8

45.1

32.8

29.4

Hypertension,%

10.1

12.1

23.3

21.2

Measurements

   Urine protein, mg/day

572 ± 1,871

744 ± 2,366

1,231 ± 2,236

2,050 ± 3047

0.0001

   T¹⁾

a

a, b

b

c

   WBC, mm³

7,420 ± 3,116

7,534 ± 3,112

7,940 ± 3,003

7,909 ± 2,967

0.252

   Hb, g/dL

12.5 ± 1.7

12.5 ± 1.7

11.6 ± 1.9

10.8 ± 1.8

0.0001

   T¹⁾

a

a

b

c

   Platelet, mm³

276,222 ± 103,955

259,255 ± 92,563

250,831 ± 96,831

235,755 ± 87,964

0.002

   T¹⁾

a

a, b

a, b

b

   Protein, g/dL

6.7 ± 3.3

6.6 ± 0.9

6.7 ± 3.8

6.3 ± 0.8

0.447

   Albumin, g/dL

3.8 ± 0.7

3.8 ± 0.6

3.6 ± 0.7

3.5 ± 0.6

0.0001

   T¹⁾

a

a

a, b

b

   Total cholesterol, mg/dL

204 ± 93

208 ± 71

207 ± 87

205 ± 72

0.215

   LDL Cholesterol, mg/dL

126 ± 55

113 ± 44

109 ± 34

112 ± 40

0.103

   HDL cholesterol, mg/dL

46 ± 16

45 ± 16

42 ± 14

40 ± 12

0.001

   T¹⁾

a

a, b

b, c

c

   Triglycerides, mg/dL

170 ± 360

151 ± 127

155 ± 95

180 ± 192

0.657

   AST, IU/L

29 ± 27

29 ± 20

27 ± 16

29 ± 38

0.108

   ALT, IU/L

28 ± 25

28 ± 23

24 ± 20

26 ± 47

0.197

   Fasting blood glucose, mg/dL

153 ± 81

142 ± 74

127 ± 62

127 ± 69

0.0001

   T¹⁾

a

a, b

b

b

   BUN, mg/dL

12.5 ± 4.5

16.1 ± 5.6

24.3 ± 9.4

38.1 ± 15.5

0.0001

   T¹⁾

a

a

b

c

   Creatinine, mg/dL

0.71 ± 0.13

0.96 ± 0.16

1.51 ± 0.33

2.86 ± 0.69

0.0001

   T¹⁾

a

b

c

d

   Total Bilirubin, mg/dL

0.77 ± 0.22

0.76 ± 0.21

0.72 ± 0.22

0.67 ± 0.21

0.0001

   T¹⁾

a, b

a, b

b, c

c

   Direct Bilirubin, mg/dL

0.31 ± 0.09

0.30 ± 0.09

0.30 ± 0.10

0.28 ± 0.09

0.222